Skip to main content

WVU Cancer Institute participates in groundbreaking study on new cancer drug

Portrait of Patrick Ma at his desk
The WVU Cancer Institute is one of several sites nationwide that participated in a groundbreaking clinical research study of a novel drug proven very effective in the treatment of pediatric and adult cancers that carry a specific genetic mutation. Patrick Ma, MD, principal investigator of the Cancer Institute study, co-authored an article about the drug in the New England Journal of Medicine.